Clinical Trials Logo

KRAS Gene Mutation clinical trials

View clinical trials related to KRAS Gene Mutation.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03808558 Recruiting - KRAS Gene Mutation Clinical Trials

Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas

Start date: September 11, 2019
Phase: Phase 2
Study type: Interventional

This is a prospective one-arm, two-stage phase 2 trial of TVB-2640 in KRAS mutant NSCLC patients. 13 patients will be treated with a minimum of 1 cycle of TVB-2640 therapy over 8 weeks.